The aubergine cancer breakthrough 80,000 success stories and counting!

Preventing a health problem is always better than treating it, even if the treatment is successful. Elsewhere in this month’s Nutrition & Healing you’ve read about the health hazards of sunscreens, and other effective ways of preventing skin cancer with diet, supplements, and protective clothing and shade.

But if you do get squamous or basal cell skin cancer despite all these measures, there’s a safe natural alternative available that is proving successful against the large majority of these cancers within eight to 14 weeks. (Although if you have a very large one, it may take longer.)

Even better – if you’re a scientist or an engineer – the molecular ‘mechanism of action’ (exactly how it works) of this extract has been known for over 20 years.

Extracts from plants of the Solanaceae family (Solanum genus, which includes aubergine, tomato, potato, ‘Bell’ peppers and tobacco) were reported effective in fighting cancer as long ago as 1825. But scientific investigation of the anticancer effects appears to have been delayed until the second half of the 20th century and the first few years of the 21st.

Now the research is starting to catch up, and this skin cancer breakthrough is finally getting the attention it deserves.

Dramatic results in as little as 3 weeks

Reported research started with experimental animals and human cancer lines. Effectiveness was demonstrated against sarcoma in mice, and against human melanoma and ovarian cancer cell lines. Animal toxicity studies were also done, showing a wide margin of safety in cancer-free animals, a margin which tripled in animals with cancer

The first reported study of basal cell cancer, squamous cell cancer and actinic keratosis used an aubergine extract called Curaderm-BEC5 and a placebo. Individuals with basal cell cancer, squamous cell cancer, and actinic keratosis were enrolled. (Actinic keratosis is a small, raised patch of skin, featuring dry, rough, yellowish or brownish scales, almost always occurring on sun-exposed skin of individuals past 50.)

Thirty individuals had basal cell cancers, usually a form that spreads locally if untreated. One hundred per cent (28 of 28) using Curaderm-BEC5 had complete regression of all of their basal cell cancers (some had more than one) within three to 13 weeks. Neither of the two using the placebo had improvement after 14 weeks.

Twenty individuals had squamous cell cancers, a form which starts and spreads locally but can metastasise. Again, 100 per cent (20 of 20) had complete regression of their squamous cell cancers within three to 11 weeks. There were no placebo treatments in this group.

Thirty-six individuals had actinic keratoses. Yet again, 100 per cent (24 of 24) using Curaderm-BEC5 had complete regression within one to four weeks. And of the 12 using the placebo, NONE had any improvement at all in 14 weeks.

Another small study that used a slightly different version of Curaderm-BEC5 (CuradermBEC2) also had dramatic results:

  • 13 individuals with 24 basal cancers had 83 per cent complete regression within four to seven weeks
  • 5 individuals with six squamous cell cancers also had 83 per cent regression within four to 12 weeks, and
  • 8 individuals with 23 actinic keratoses had 100 per cent regression within two to six weeks.

It works… but is it safe?

In a letter dated 23 April 2002, Dr. Rino Cerio and Dr. Sangeeta Punjabi of the Dermatology Department of the Royal London Hospital describe their experience with CuradermBEC5 treatment of basal cell carcinoma in two clinical trials.

The first was a placebo-controlled, double-blind, multi-centred study of 94 patients. Initially, these cancers were diagnosed as non-invasive basal cell cancers, but later punch biopsies showed that several of the patients actually had an invasive form. However, the doctors reported that in either the invasive or non-invasive form, approximately 78 per cent had complete regression within eight weeks.

The second trial with 41 individuals was done only at Royal London Hospital and was mostly to assess safety, so no placebo was used. Complete regression in this trial “paralleled the multi-center efficacy rate of 78 per cent.

About safety, the doctors wrote: “Our clinical experience has shown that CuradermBEC5 is safe.” They noted that with twice daily use under an occlusive dressing, only a few patients noted skin irritation and redness. Further assuring safety, blood and urine tests showed there was no systemic absorption of Curaderm-BEC5.

They pointed out that with the occlusive dressing, CuradermBEC5 results in ulceration of the cancer site during treatment. After treatment, the ulceration is “quickly replenished with normal tissue and that residual scarring is minimal.” The cosmetic outcome is “comparable to that resulting from surgical excision.”

They pointed out that with the occlusive dressing, CuradermBEC5 results in ulceration of the cancer site during treatment. After treatment, the ulceration is “quickly replenished with normal tissue and that residual scarring is minimal.” The cosmetic outcome is “comparable to that resulting from surgical excision.”

They pointed out that with the occlusive dressing, CuradermBEC5 results in ulceration of the cancer site during treatment. After treatment, the ulceration is “quickly replenished with normal tissue and that residual scarring is minimal.” The cosmetic outcome is “comparable to that resulting from surgical excision.”

Curaderm-BEC5 is a name for a mixture of 1/3 solasonine and 1/3 solamargine in the triglycoside form, and 1/3 diglycosides and monoglycosides of these two basic molecules. By themselves, solasonine and solamargine don’t have anticancer activity, as they can’t penetrate into cells, cancerous or normal. But one of the attached simple sugars (rhamnose, a plant sugar rarely found in mammals) can attach itself to receptors present in skin cancer (or actinic keratosis) cell membranes only, receptors not found in the membranes of normal skin cells.

Once the glycoside-solasonine or glycoside-solamargine complex (Curaderm-BEC5) attaches to the cancer cell membrane, it’s transported inside, where it causes cancer cell death by destroying cell components called lysosomes. Normal cells escape any harm, since the Curaderm-BEC5 can’t get into them.

The best recent review of BEC-5, complete with many pictures, charts, graphs, and 57 citations, is downloadable for free from www.scirp.org/ journal/PaperDownload. aspx?paperID.

Ten years later, and the cancer still hasn’t returned!

Dr. Bill Cham has developed BEC since the 1980s. He notes that Curaderm-BEC5 is effective at extremely low doses. Just one 300g (approximately 11-ounce) aubergine contains the same amount of Curaderm-BEC5 as do 60 tubes of the over-the-counter preparation. Once a cancer or actinic keratosis has completely regressed, as research has shown it does in the large majority of cases, up to 10-year follow-up shows it doesn’t recur.

Dr. Cham writes: “CuradermBEC5 is applied at least twice daily to the skin and may be applied much more frequently if rapid regression of the tumour is required. Some patients apply the Curaderm-BEC5 cream up to 10 times daily. The cosmetic results after using Curaderm-BEC5 are very impressive and over 80,000 patients have now used Curaderm-BEC5 successfully.”

However, it’s important to note that even though these research results (done with humans) are very good, they may not apply to you.

Since December 2005, I have observed only two individuals who could not use it due to extreme hypersensitivity to its salicylate content, which is included to aid penetrability. All others using it have gotten rid of their cancers. The cancers I’ve observed were mostly small ones, although the pictures in Dr. Cham’s book The Eggplant Cancer Cure include some quite large ones. [Please note that in the US aubergines are called eggplants.]

You can obtain CuradermBEC5 from the Tahoma Clinic Dispensary in the US (1-888-8936878, www.tahoma-clinic.com), or online from International Antiaging Systems (www. antiaging-systems.com).

You can order The Eggplant Cancer Cure by Dr. Cham through the Tahoma Clinic Dispensary and many online sources.

As always, consult with a doctor skilled and knowledgeable in nutritional and natural medicine. As even skin cancer (especially squamous cell cancer) can be very dangerous if neglected, it’s always wisest to consult a dermatologist, too, for as exact a diagnosis as possible.

Wishing you the best of health,

Dr. Jonathan V. Wright
Editor
Nutrition & Healing

Volume 6, Issue 04 – April 2012


Full references and citations for this article are available in the downloadable PDF version of the monthly Nutrition and Healing issue in which this article appears.

Leave a comment

Be part of the conversation by becoming a Premium Member. Click here to learn more about membership.


Leave a Reply

Your email address will not be published. Required fields are marked *